Probability of biopsy-detectable prostate cancer (PCPTRC 1.0) - Evidencio
Probability of biopsy-detectable prostate cancer (PCPTRC 1.0)
Calculates the probability of biopsy-detectable prostate cancer according to the prostate cancer prevention trial risk calculator 1.0 (c-index: 0.70). 

Note: This model is only applicable for persons without a previous diagnosis of prostate cancer.
Auteurs: Thompson IM, Ankerst DP, Chi C, Goodman PJ, Tangen CM, Lucia MS, Feng Z, Parnes HL, Coltman CA Jr.
Versie: 1.40
  • Publiek
  • Oncologie
  • {{ modelType }}
  • Details
  • Valideer algoritme
  • Bewaar invoer
  • Laad invoer
Weergave
Eenheden

{{ section.title }}

{{ section.description }}

Bereken het resultaat

Vul meer parameters in om de berekening uit te voeren

Probability of biopsy-detectable prostate cancer:

{{ resultSubheader }}
{{ $t('download_result_availability') }}
{{ chart.title }}
Resultaat interval {{ additionalResult.min }} tot {{ additionalResult.max }}

Conditionele informatie

This predictive model allows an individualized assessment of prostate cancer risk and risk of high-grade disease for men who undergo a prostate biopsy. No specific level of risk is recommended for prostate biopsy and this decision should be an individual choice based upon a physician-patient relationship.

Applicability of the model:  
Most men in the underlying study by Thompson et al (2006) were white and results may be different with other ethnicities or races. The calculator is in principle only applicable to men under the following restrictions:

  • Age 55 or older
  • No previous diagnosis of prostate cancer
  • DRE and PSA results less than 1 year old

Model performance: 
The average out-of-sample discriminative power (c-index) for the model by Thompson et al (2006) was 0.70. 

Modification of the PCPTRC:
In 2012, the updated PCPTRC 2.0 was released with the added capability to provide prediction of low-grade (Gleason grade < 7) versus high-grade prostate cancer. PCPTRC 2.0 was based on re-analysis of an expanded set of 6664 biopsies from 5826 patients from the PCPT placebo arm. Characteristics of the patients and biopsies forming PCPTRC 2.0 are similar to those used for the original PCPTRC, but the new PCPTRC 2.0 generally provides lower risk estimates due to the inclusion of multiple prior negative biopsies per individual rather than just one biopsy per person. 

{{ file.classification }}
PRO
Notitie
Notities zijn alleen zichtbaar in de resultaat download en worden niet opgeslagen door Evidencio

Dit algoritme wordt verstrekt voor educatieve, opleidings- en informatieve doeleinden. Het mag niet worden gebruikt ter ondersteuning van medische besluitvorming, of om medische of diagnostische diensten te verlenen. Lees onze volledige disclaimer.

Onderliggende algoritmes Onderdeel van
Opmerkingen
Opmerking
Vul een opmerking in.
Opmerkingen zijn voor iedereen zichtbaar

Algoritme feedback

Nog geen feedback 1 Opmerking {{ model.comments.length }} Opmerkingen
Op {{ comment.created_at }} {{ comment.user.username }} een niet langer geregistreerde auteur schreef:
{{ comment.content }}
logo

Log a.u.b. in om de Evidencio print-functies te gebruiken

Om de Evidencio print-functies te kunnen gebruiken dient u ingelogt te zijn.
Indien u nog geen Evidencio Community Account heeft kunt u eenvoudig een persoonlijk account aanmaken op:

https://www.evidencio.com/registration

Print rapport - Voorbeelden {{ new Date().toLocaleString() }}


Evidencio Community Account voordelen


With an Evidencio Community account you can:

  • Create and publish your own prediction algorithms.
  • Share your prediction algorithms with your colleagues, research group, organization or the world.
  • Review and provide feedback on algorithms that have been shared with you.
  • Validate your algorithms and validate algorithms from other users.
  • Find algorithms based on Title, Keyword, Author, Institute, or MeSH classification.
  • Use and save prediction algorithms and their data.
  • Use patient specific protocols and guidelines based on sequential algorithms and decision trees.
  • Stay up-to-date with new algorithms in your field as they are published.
  • Create your own lists of favorite algorithms and topics.

A personal Evidencio account is free, with no strings attached!
Join us and help create clarity, transparency, and efficiency in the creation, validation, and use of medical prediction algorithms.


Disclaimer: Predictie algoritmes dienen enkel ter ondersteuning en naslag geraadpleegd te worden en zijn geen vervanging voor medische besluitvorming door professionals.
Evidencio v3.38 © 2015 - 2025 Evidencio. Alle rechten voorbehouden